The Food Label and You (Historical PSA)

Are you smarter than a food label? Find out on our quiz show spoof with host, "Labelman". Plus-CSI ("Calorie Scene Investigator"), a play-by-play sports show battle between two dinner parties, nutrition at the drive-through and more. Produced by FDA's Division of Communication Media for CFSAN. [vpfood] NOTE: FDA has issued final changes to update the Nutrition Facts label for packaged foods. For more information, read the Changes to the Nutrition Facts Label webpage: https://www.fda.gov/food/food-labelin...

FDA's Role in Improving Nutrition: Labeling and Other Authorities
▶︎

FDA's Role in Improving Nutrition: Labeling and Other Authorities

The Food Label and You: Game Show Review (Are You Smarter Than A Food Label?) (Historical PSA)
▶︎

The Food Label and You: Game Show Review (Are You Smarter Than A Food Label?) (Historical PSA)

Fresh and Frozen Seafood: Selecting and Serving it Safely
▶︎

Fresh and Frozen Seafood: Selecting and Serving it Safely

The Food Label and You: The 5-20 Rule Part 1 (Historical PSA)
▶︎

The Food Label and You: The 5-20 Rule Part 1 (Historical PSA)

FDA Direct with Dr. Martin Makary, FDA Commissioner
▶︎

FDA Direct with Dr. Martin Makary, FDA Commissioner

FDA Direct - Special Edition of FDA Direct
▶︎

FDA Direct - Special Edition of FDA Direct

MEDIA CALL: Front of Package Nutrition Labels – 1/14/2025
▶︎

MEDIA CALL: Front of Package Nutrition Labels – 1/14/2025

AGDD 2025 | D1S02 - Novel Bioequivalence Study Design Recommendations
▶︎

AGDD 2025 | D1S02 - Novel Bioequivalence Study Design Recommendations

The Food Label and You: Servings (Historical PSA)
▶︎

The Food Label and You: Servings (Historical PSA)

CDER Small Business and Industry Assistance Overview (12of14) REdI 2018
▶︎

CDER Small Business and Industry Assistance Overview (12of14) REdI 2018

AGDD 2025 | D1S01 - Product-Specific Guidance for Complex Products: From Research to Standards
▶︎

AGDD 2025 | D1S01 - Product-Specific Guidance for Complex Products: From Research to Standards

AGDD 2025 | D2S03 - Common Deficiencies and Resolutions: Complex Drug Substance/Excipients/Products
▶︎

AGDD 2025 | D2S03 - Common Deficiencies and Resolutions: Complex Drug Substance/Excipients/Products

FDA Grand Rounds: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context & Recent Changes
▶︎

FDA Grand Rounds: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context & Recent Changes

AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice
▶︎

AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice

Considerations for Collecting/Using Natural History Data Fit for Use in the Regulatory Setting
▶︎

Considerations for Collecting/Using Natural History Data Fit for Use in the Regulatory Setting

AGDD 2025 | D1S03 - Day One Closing Remarks
▶︎

AGDD 2025 | D1S03 - Day One Closing Remarks

AGDD 2025 | D2S05 - Workshop Closing Remarks
▶︎

AGDD 2025 | D2S05 - Workshop Closing Remarks

Understanding Endpoints in Rare Disease Drug Development
▶︎

Understanding Endpoints in Rare Disease Drug Development

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
▶︎

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

Office of New Drugs Standard Safety Tables and Figures for New Drug and Biologic Applications
▶︎

Office of New Drugs Standard Safety Tables and Figures for New Drug and Biologic Applications